Merdury Biopharmaceutical (6932.TWO) Stock Price
Merdury Biopharmaceutical Price
Revenue has compounded at 36.1% per year over the past 2 years to 4.96 M TWD. Merdury Biopharmaceutical's net margin stands at -1,018.9%, up from -1,166.0% several years earlier.
Merdury Biopharmaceutical stock price
Merdury Biopharmaceutical business model & stock analysis
Frequently asked questions about Merdury Biopharmaceutical
Converted at the current exchange rate, the Merdury Biopharmaceutical share trades at 0.20 EUR (7.04 TWD).
The revenue cannot currently be calculated for Merdury Biopharmaceutical.
The profit cannot currently be calculated for Merdury Biopharmaceutical.
The P/E ratio cannot be calculated for Merdury Biopharmaceutical at the moment.
The P/S cannot be calculated for Merdury Biopharmaceutical currently.
The Eulerpool Quality Score for Merdury Biopharmaceutical is 2/10.
The ISIN of Merdury Biopharmaceutical is TW0006932007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Merdury Biopharmaceutical is 6932.TWO. The ticker symbol is used to trade Merdury Biopharmaceutical shares on the stock exchange.
Merdury Biopharmaceutical stock
Merdury Biopharmaceutical Peer Group
Merdury Biopharmaceutical FIGI
All fundamentals and in-depth analysis of Merdury Biopharmaceutical
Our stock analysis for Merdury Biopharmaceutical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merdury Biopharmaceutical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.